| 10.01.03 |
Formulary
|
 |
Adalimumab injection rheumatology indications |
| 01.02 |
Restricted Use
|
|
Aprepitant caps, oral suspension gastroparesis - off-label |
| 01.02 |
Formulary
|
|
Botulinum toxin A chronic sialorrhoea - Xeomin® |
| 01.02 |
Restricted Use
|
|
Botulinum toxin A Xeomin® - gastroenterology endoscopic indications off-label |
| 01.07.04 |
Restricted Use
|
|
Botulinum toxin A Xeomin® - anal-fissures - off-label |
| 10.01.03 |
Formulary
|
|
Certolizumab pegol injection |
| 09.05.01.02 |
Restricted Use
|
|
Cinacalcet tablets secondary hyperparathyroidism in ESRD |
| 02.01.01 |
Formulary
|
|
Digoxin specific antibody fragments |
| 10.01.03 |
Formulary
|
|
Etanercept injection rheumatology indications |
| 01.05.03 |
Formulary
|
|
Golimumab injection ulcerative colitis |
| 10.01.03 |
Formulary
|
|
Golimumab injection rheumatology indications |
| 01.05.03 |
Formulary
|
|
Infliximab injection cancer immunotherapy related colitis - off-label |
| 10.01.03 |
Formulary
|
|
Infliximab injection licensed rheumatology indications |
| 08.03.04.03 |
Formulary
|
|
Octreotide injection off-label uses |
| 08.02.03 |
Restricted Use
|
|
Rituximab injection TTP - off-label |
| 09.01.04 |
Formulary
|
|
Rituximab injection immune thrombocytopenia - off-label |
| 10.01.03 |
Formulary
|
|
Rituximab injection rheumatology - licensed indications |
| 10.01.03 |
Formulary
|
|
Sarilumab pre-filled pen or syringe |
| 10.01.03 |
Formulary
|
|
Secukinumab injection ankylosing spondylitis & psoriatic arthritis |
| 10.01.03 |
Formulary
|
|
Tocilizumab injection arthritis |
| 01.05.03 |
Formulary
|
|
Tofacitinib tabs gastroenterology indications |
| 10.01.03 |
Formulary
|
|
Tofacitinib tabs rheumatology indications |
| 01.05.03 |
Formulary
|
|
Ustekinumab injection gastrointestinal indications |
| 10.01.03 |
Formulary
|
|
Ustekinumab injection psoriatic arthritis |
